These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The drug treatment of leprosy. Browne SG Practitioner; 1975 Oct; 215(1288):493-500. PubMed ID: 1202470 [No Abstract] [Full Text] [Related]
5. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance. Pearson JM; Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115 [No Abstract] [Full Text] [Related]
6. Chemotherapy in Leprosy. Leiker DL Int J Dermatol; 1975 May; 14(4):254-62. PubMed ID: 1093982 [No Abstract] [Full Text] [Related]
7. A survey of the drugs with activity against M. leprae in mice. Shepard CC Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080 [No Abstract] [Full Text] [Related]
8. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae. Pattyn SR Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832 [No Abstract] [Full Text] [Related]
9. Correlation of laboratory and clinical data during treatment of leprosy. Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223 [No Abstract] [Full Text] [Related]
10. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana]. Jamet P; Robin Y Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of leprosy. Leiker DL Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084 [No Abstract] [Full Text] [Related]
12. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368 [No Abstract] [Full Text] [Related]
13. [New drugs in the treatment of leprosy]. De Las Aguas JT Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391 [TBL] [Abstract][Full Text] [Related]
14. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy. Freerksen E; Rosenfeld M Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384 [No Abstract] [Full Text] [Related]
15. Drug resistance and multi-drug therapy in leprosy. Chatterjee BR Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881 [No Abstract] [Full Text] [Related]
16. Clofazimine in leprosy. Browne SG Br Med J; 1972 Feb; 1(5798):506-7. PubMed ID: 4550304 [No Abstract] [Full Text] [Related]
17. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy]. Vischer WA Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384 [No Abstract] [Full Text] [Related]
18. Treatment of paucibacillary leprosy by WHO regimen. Dey SK; Chanda M; Chowdhury A; Panja SK Indian J Dermatol; 1987 Jan; 32(1):11-3. PubMed ID: 3453349 [No Abstract] [Full Text] [Related]
19. The treatment of leprosy and its acute complications. Jopling WH Trop Doct; 1973 Jan; 3(1):8-11. PubMed ID: 4120944 [No Abstract] [Full Text] [Related]
20. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]